Lumiphore lumiphore.com


Public lists: Medical Devices (6146)

Lumiphore is a research company developing lanthanide technology for use in high-value applications and commercializing the technology by entering into market-specific alliances with corporate partners. Lumiphore develops and markets biological detection systems based on luminescent lanthanide complexes, which provide a combination of sensitivity, reliability, flexibility and high throughput.

Lumiphore is a research company developing lanthanide technology for use in high-value applications and commercializing the technology by entering into market-specific alliances with corporate partners. Lumiphore develops and markets biological dete...Show all

Company (Alive / Active)

Phone:

Fax:

4677 Meade Street
Suite 216
Richmond, 94804
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Lumiphore $0M Mar 19, 2019
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Lumiphore Jobs

jobs by Indeed job
						search
There is no Investors data available for this company. Please select another tab.

Board Members

Competitors

Company Status Description Investors

Cellpoint Diagnostics

La Jolla, California, United States
Alive / ActiveCellPoint Diagnostics is developing diagnostic, monitoring, and molecular analytical tools for cancer. Its technology captures and analyzes circulating tumor cells ("CTCs") directly from patient blood. Scientific and clinical data have demonstrated that CTCs are derived from the primary tumor, and the assessment of the number of CTCs in the blood has been shown to accurately predict survival for cancer patients.Login to see details

Micronics Microfluidics

Redmond, Washington, United States
AcquiredMicronics is advancing a portfolio of point of care products for disease detection, diagnosis and treatment monitoring. The company employs an estate in microfluidics and related technologies that make it possible to process biological and environmental samples directly in disposable devices and to perform highly accurate and affordable tests in a fraction of the time required by most molecular diagnostic tests in use today. Micronics is involved in the research and development of near patient ...Show allLogin to see details
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Multiplexed homogeneous oligonucleotide detection May 25, 2015 Mar 13, 2018 Patent
Macrocyclic hopo chelators Aug 24, 2010 Mar 01, 2016 Patent
Multi-color time resolved fluorophores based on macrocyclic lanthanide complexes Jan 25, 2008 Aug 13, 2013 Patent
Macrocyclic hopo chelators Feb 25, 2016 Application
Functionalized linear ligands and complexes thereof Dec 21, 2015 Application
See all 7 patents